Aaron Mansfield

Thoracic oncologist at Mayo Clinic. Tweets my own.

[Dr. Estela Rodriguez @Latinamd]

#TTLC26 @AMansfieldMD @MayoClinic presents highlights of current research in #pleuralmesothelioma targeting:
➡️ MTAP deletion (PRMT5i)
➡️ TROP2 (ADCs)
➡️ Argininosuccinate synthetase 1 (ASS1) deficiency (ADI-PEG20)
👉🏽still a lot of work to do to optimize surgery, early detection and treatment for pts w this rare disease @curemeso #lcsm

[Stephen V Liu, MD @StephenVLiu]

Great collaboration with @SWaliany @JessicaJLinMD @alissajcooper @GautschiOliver @JuliaRotow @UrsWeberMD @herbloong @JPatelMD @n8pennell @MNagasaka @danieltanmd @bensolomon1 @PallGeorg @riess_md @LovaSunMD @NatalieUyMD @ShirishGadgeel @oncoOuLungCA @TejasPatilMD @AMansfieldMD @JustinGainor @alexdrilon

[TLC Conference @TLCconference]

Dive into the complexities of mesothelioma, thymic cancers, and other uncommon thoracic cancers. Join moderator Dr. @marinagarassino and expert panelists Drs. @SheenaBhallaMD, @SBroderickMD, @ErinGillaspie, @AMansfieldMD, @jennifermarksmd, @dwightowenmd, and @Joshua_Reuss for this deep dive at #TexasLung26! We're making it easy: FREE REGISTRATION for a limited time to the 2-day CE-accredited conference April 9–11, 2026 at @acllive in Austin, TX. Grab your spot now with promo code FREECME! https://t.co/dzMIy2CY56 #LungCancer #RareTumors #ThoracicOncology

[Aaron Mansfield @AMansfieldMD]

@deeptibehl1 @kaushalpar @OncoThor @KLeventakos @MayoCancerCare Your kind words mean a lot to me. Thank you.

[Aaron Mansfield @AMansfieldMD]

@deeptibehl1 @MayoCancerCare @KLeventakos @kaushalpar @OncoThor We’re lucky to have you on our team!

[Alliance for Clinical Trials in Oncology @ALLIANCE_org]

A082101 led @AMansfieldMD of @MayoClinic evaluates the safety & effectiveness of immunotherapy before surgery for #mesothelioma. #Immunotherapy helps the body’s immune system fight cancer. Learn more: https://t.co/a8IpbGHcvZ @thenci #nctn

[Stephen V Liu, MD @StephenVLiu]

Congratulations to Dr. @zhang_yongchang and his prospective phase III trial showing the impact of time of infusion on survival with immunotherapy in NSCLC. A no cost intervention that can have a huge impact. One of the top #ASCO25 presentations for me this year.

[Aaron Mansfield @AMansfieldMD]

@ADesaiMD @MayoCancerCare @KLeventakos @IASLC @ONealCancerUAB @AmitMehtaMD @arnabguonc @BasselElRayesMD @ReasorErica Congratulations! Proud of you.

[Aaron Mansfield @AMansfieldMD]

Congratulations Kaushal! I’m proud of you. It is wonderful to see all of your hard work being recognized with this opportunity.

Thank you @aadel_chaudhuri for your co-mentorship!

[Aadel Chaudhuri, MD PhD @aadel_chaudhuri]

Proud of @kaushalpar for the @ASCO @ConquerCancerFd CDA Award!

Couldn’t be any prouder than I am ☺️

@AMansfieldMD @MayoCancerCare @MayoClinic

[Dipesh Uprety MD FACP @DipeshUpretyMD]

Dear @IASLC members,
I am proud to support Dr. Adjei's nomination for the IASLC President-an outstanding mentor, a passionate patient advocate, a lifelong teacher, exceptional clinician and truly remarkable human being. Please join me in supporting his candidacy #LCSM @OncoAlert

[Aaron Mansfield @AMansfieldMD]

It is always great to see you @Latinamd and catch up. I appreciate the kind words. #curemeso

[Dr. Estela Rodriguez @Latinamd]

#TexasLung25 So great to catch up with @AMansfieldMD @MayoClinic one of the leading #mesothelioma researchers in the US. Always grateful for his advice & guidance with difficult cases in this rare disease (in need of more research investment).
#lcsm #mesothelioma

[Joshua Reuss @Joshua_Reuss]

Insightful discussion on rare thoracic malignancies - thymoma/thymic carcinoma & mesothelioma at #TexasLung25. Challenging malignancies to diagnose and treat, often requiring sub-specialty and multi-d input.

[TLC Conference @TLCconference]

We are less than 2 weeks away from #TexasLung25! Don’t miss the session on rare thoracic tumors led by Dr. @marinagarassino with Drs. @MMarmarelis, @chulkimMD, @LorettaEMD, @AMansfieldMD, @LuisRaezMD, @jennifermarksmd Register today for this 2-day CE-accredited conference. https://t.co/WmyKm1MCyV

[Aaron Mansfield @AMansfieldMD]

@JakeOrmeMDPhD @MayoClinic @MayoCancerCare @flscientist Congratulations on this publication and taking the early findings on soluble PD-L1 to trial with the team. Great job!

[Jake Orme MD PhD @JakeOrmeMDPhD]

So grateful to the brave patients and their families that made this clinical trial possible, an entirely new way to restore sensitivity to immunotherapy using plasma exchange. @MayoClinic @MayoCancerCare @flscientist
Nat Comm https://t.co/LdrTp8CaUS

[Aadel Chaudhuri, MD PhD @aadel_chaudhuri]

Excited to present our liquid biopsy research to the thoracic disease group across the enterprise @MayoCancerCare @MayoClinic!

Thank you especially to @AMansfieldMD for the invitation. ☺️

[Aaron Mansfield @AMansfieldMD]

@VamsiVelcheti @MayoClinic @RManochakian @kaushalpar Really looking forward to working with you!

[Herbert Loong, MBBS, FASCO @herbloong]

Always nice to meet #LCSM #friends from around the #world 🌎! Thanks @IASLC #TTLC25 for providing a platform for collaborations, discussions and just for hanging out! @VamsiVelcheti @AMansfieldMD @ElaineShumMD and many others! @APCLC_2023 @apoddc @CUHKMedicine

[Mayo Clinic Center for Individualized Medicine @MayoClinicCIM]

Even the most advanced cancer therapies can’t work if tumors don’t absorb them. Mayo Clinic researchers, led by @AMansfieldMD, are pioneering a strategy to help targeted treatments get inside cancer cells. Discover more: https://t.co/BowIWBW45D

[ASCO @ASCO]

We've issued a new guideline update on the treatment of pleural #mesothelioma: https://t.co/dSLXcXETqO